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Abstract

Our client, Dr. George Lykotrafitis of the Biomedical and Mechanical Engineering
Departments at the University of Connecticut, requested the design of a simple, portable,
inexpensive device to measure whole blood viscosity (WBV) under oxygenated and
deoxygenated conditions. WBV is affected by diseases such as sickle cell disease (SCD) and
cardiovascular disease, conditions that can lead to serious or lifethreatening conditions and
largely affect individuals in areas with little access to healthcare [2][3][4][5]. While WBV is
recognized as a pointofcare measurement for conditions such as SCD and cardiovascular
disease, the use of conventional rheometers in areas without healthcare facilities is not practical
as testing methods are expensive, time consuming, require large blood samples, and/or are not
usable outside of a laboratory setting [5][6]. Here, a microfluidic rheometer is proposed for the
measurement of WBV. The device employs capillary pressure to drive the flow of a reference
fluid of known viscosity and a blood sample through a microfluidic array. The WBV of the
blood sample is calculated using the known channel dimensions, capillary pressure, reference
fluid viscosity, and sample fluid velocity. The microfluidic device will be fabricated using a wet
chemical etching method and has a projected cost of approximately $1.40 per device if produced
on a commercial scale. The proposed device is novel in that it requires a small blood sample, is
portable, does not require power, and allows for measurement of WBV over a range of shear
rates that are clinically meaningful. It overcomes the obstacles that limit the operation of
currently available viscometers outside of a laboratory setting and meets the client specified
objectives of portability, simplicity, and cost.
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1. Introduction
1.1 Background
Our client, Dr. George Lykotrafitis of the Mechanical and Biomedical Engineering
Departments at the University of Connecticut, is seeking a novel device to measure whole blood
viscosity WBV in a simple, costeffective manner. Dr. Lykotrafitis directs the Cellular
Mechanics laboratory at the University of Connecticut. The laboratory’s research includes work
involving sickle cell disease SCD, a condition that is known to affect WBV [1]. Individuals
affected by SCD have erythrocytes that take on a characteristic sickle shape when deoxygenated
instead of the normal biconcave shape. To facilitate the study of the full range of behavior of
sickle cell erythrocytes, Dr. Lykotrafitis’s lab is equipped to conduct experiments under both
oxygenated and deoxygenated conditions. Consequently, the proposed device should be
operable in both an oxygenated and a deoxygenated environment.
The client has indicated the relevance of the device not only to his own research but to
public health as well. The impacts of SCD are widespread; the disease occurs in >200,000 births
per year in Africa and between 60,000 and 100,000 births per year elsewhere [2]. Patients with
SCD exhibit a range of symptoms including chronic pain, frequent infections, necrosis, organ
damage, and stroke [3][4]. The significance of altered blood rheology on the prognosis and the
need for preventative care in SCD is established [5]. Commercial rheometers currently utilized
for the measurement of WBV, however, involve methods that are performed using expensive
equipment, are time consuming, require a large blood sample on the order of milliliters, and are
not practical outside of a laboratory setting [6]. This may present a barrier to treatment,
particularly in those areas in which individuals do not readily have access to healthcare and/or
medical facilities. An ideal device would offer a simple, portable, inexpensive means to measure
WBV.
The proposed device has clear applications to the measurement of WBV in SCD. The
clinical relevance of the device, however, extends beyond this scope. Abnormal WBV is a
means for early diagnosis, prognosis, and prevention in many other diseases [5]. In patients with
cardiovascular disease, increased WBV has been correlated with an increased risk of
cardiovascular events [7]. Cardiovascular disease, a diagnosis which encompasses conditions
such as coronary heart disease, deep vein thrombosis, and peripheral arterial disease, results in
more annual deaths worldwide than any other cause [8]. According to the World Health
Organization, this trend is expected to continue in the future [8]. Like SCD, many of the
individuals significantly impacted by cardiovascular disease live in areas with barriers to proper
care, with 80% of the annual deaths resulting from the condition occurring in low to
middleincome countries [8]. Monitoring WBV shows promise as a pointofcare measurement
in patients with cardiovascular disease and the application of the proposed device for this
purpose is but one example of the relevance of the device beyond the scope of SCD [7].
1.2 Purpose
Aim: 
The goal of this project is to design, fabricate, and assess the performance of a simple
and preferably inexpensive device that can measure WBV and its changes over time.
It has been established that WBV is increased in patients with cardiovascular disease as
well as in patients with sickle cell anemia [1][7]. The viscosity of blood can also vary throughout
4

the course of procedures such as cardiopulmonary bypass. Here, the aim is to design, fabricate,
and test a simple device that can accurately measure the viscosity of whole blood. The client has
stated that such a device should be easy to operate, inexpensive to fabricate, and preferably
usable outside of a laboratory setting. Considering that the client is particularly interested in
measurements of blood viscosity in SCD, the device will be designed to perform in both an
oxygenated and deoxygenated environment.
1.3 Previous Work Done by Others

Our optimal design uses a microfluidics approach to the design of the device. We are
aware of two research teams currently investigating microfluidicsbased viscometers for use with
nonNewtonian fluids such as whole blood. Kang, et al. have designed viscometers for the
measurement of WBV that utilizes a microfluidic device in conjunction with a syringe pump
[9][10].
i.

ii.

Fig. 1
. i. Microfluidic device by Kang, et al. for the measurement of WBV [9] ii. Microfluidic
device by Kang, et al. for the simultaneous measurement of flow rate and WBV in a complex
fluidic network [10].
5

Figure 1 shows two microfluidics devices designed by Kang, et al. The device shown in Fig. 1 i.
utilizes a microfluidic device featuring two inlets for the sample and reference fluids and a
number of indicating channels. The length, width, height, and distance between indicating
channels are L=10 mm, W=50 μm, h=60 μm, and S=100 μm, respectively [9]. The sample fluid
for which the viscosity is to be determined and and a reference fluid of known viscosity are
pumped into the inlets at known flow rates Qspl and Qref [9]. Due to the fact that the pressure
drop across the channels is identical, according to Poiseuille’s law, the relative viscosity of the
sample to the reference fluid may be calculated using the equation:
(1)

μ

N

Q

ref
μr = ( μspl
) = ( Nspl
)( Qspl
)
ref
ref

where μspl and μref are the viscosity of the sample and reference fluids, and N spl and N ref are
the number of indicating channels filled with the sample and reference fluids [9]. Clearly, if μref
is known, μspl may be calculated. Further, using Qspl , N spl , W, and h, the shear rate may be
calculated using the equation:
(2)

Fig. 1 ii. shows a second device designed by Kang, et al. that utilizes a similar technique to
measure the viscosity of whole blood. This device adds the ability to measure WBV of a sample
at an unknown flow rate Qx [10]. As shown in Fig. 1 ii., the device consists of three
microfluidic channel arrangements. Similar to the first device, there are inlets for sample and
reference fluids and microfluidic channels of width and depth W=300 μm and D=50 μm. During
operation, the sample flows into the left inlet in Fig. 1 ii.a at flow rate Qx while the reference
fluid is pumped into the left inlet at known flow rate Qpbs such that the sample enters the upper
right chamber. Reference fluid is pumped into the right inlet of the second microfluidic
arrangement (Fig. 1 ii.b) at known flow rate Qpbs equal to that of the first microfluidic
arrangement. The sample is pumped into the left inlet (Fig. 1 ii.b) at flow rate Qblood such that
the number of channels filled with blood ( N blood ) is equal to that of the first microfluidic
arrangement. Consequently, it may be concluded that Qblood = Qx , allowing the unknown flow
rate of the sample to be calculated [10]. The sample is then pumped into the left inlet of the third
microfluidics arrangement at flow rate Qx = Qblood as shown in Fig. 1 ii.c. The reference fluid is
pumped into the right inlet (Fig. 1 ii.c) until the flow reverses at some flow rate Qpbs,ss and the
reference fluid flows into the left half of the device. Due to the fact that the fluidic resistance in
each of the devices is identical, the unknown viscosity of the sample may be calculated using the
equation:
(3)
μpbs∙Q
μx = Qbloodpbs
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Additionally, using Qblood and the hydraulic diameter of the channels indicated by D and N, the
shear rate of the sample in the channels may be calculated using the equation:
(4)

A different approach for the measurement of WBV has been developed by Srivastava, et al. and
Srivastava and Burns [11].

Fig. 2.
Selfcalibrating microfluidic device for measurement of WBV by Srivastava, et al. [11].
Figure 2 depicts a selfcalibrating microfluidic device for the measurement of WBV designed by
Srivastava and Burns [11]. The device exhibits two identical open microfluidic channels of
width, length, and depth W=400 μm, L=8 cm, and D=100 μm and two identical arrangements of
a microchannel joined to a sealed chamber. A sample and reference fluid are placed at the inlets
as indicated by the labels and arrows in Fig. 2. Capillary pressure draws the fluids into the open
channels and the velocity of the fluid through the channel is monitored. The capillary pressure
P capillary is determined using the microchannels joined to the sealed chambers. According to the
ideal gas law,
(5)
V
P capillary = P atm( V 12 − 1)
where P atm is the atmospheric pressure and V 1 and V 2 are the original and compressed
volumes of air in the sealed chamber, calculated based on device dimensions and the position of
7

the fluid meniscus [11]. The unknown viscosity of the sample may be calculated using the
equation:
(6)
P
vLcal
sample
μsample = μcal( P capillary,
)( capillary,
vLsample )
cal
where μsample is the sample viscosity, μcal is the calibration fluid viscosity, vLcal and vLsample
are the velocity multiplied by the length traveled by the calibration and sample fluids,
respectively, and P capillary, cal and P capillary, sample are the calculated capillary pressures of the
calibration and sample fluids.
1.3.1 Products
We are aware of no products similar to the proposed device outside of the
aforementioned research conducted by Kang, et al. and Srivastava and Burns. No commercially
available devices similar in nature were found.
1.3.2 Patent Search Results
●
Burns, et al. United States Patent. Patent No. US 7,188,515 B2. Nanoliter viscometer for
analyzing blood plasma and other liquid samples.
●
Chien, et al. United States Patent. Patent No. US 6915679 B2. Flexible, selective
transportation of fluids within microfluidic channels of a microfluidic network by
controlling pressures at reservoirs; fluid flows through the channel segments resulting from
a pressure can be determined
●
Kensey, et al. United States Patent. Patent No. US 6745615 B2. Dual riser/single capillary
viscometer.
●
Minton, et al. United States Patent. Patent No. WO 2014031639 A1. Capillary viscometer
and multiscale pressure differential measuring device.
●
Spaid, et al. United States Patent. Patent No. US 7040144 B2. Microfluidic viscometer.
●
Spaid, et al. United States Patent. Patent No. US 6990851 B2. Microfluidic viscometer.
●
Spaid, et al. United States Patent. Patent No. US 6681616 B2. Microfluidic viscometer
●
Varni, et al. United States Patent. Patent No. WO 2013066806 A1. Automated capillary
viscometer.
1.4 Report Map
The following report details the optimal design chosen for the device sought by the client.
Eliminated alternatives are described and details are given on the design of each of the
components of the chosen device, the rationale, and proposed methods for testing of the design.
The mathematical framework for the device is outlined and the fabrication methods are
discussed. The realistic constraints of the project and safety issues are considered, and the
budget and timeline of the project are detailed. Reflections on the effects of the proposed
engineering solutions and the impact on lifelong learning are included.
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2. Project Design
2.1 Introduction
The proposed design utilizes a microfluidic platform to determine the unknown viscosity
of a blood sample over a range of shear rates that are reflective of the conditions present in the
human body. The device utilizes capillary pressure to drive the flow of the sample through
serpentine microchannels of varied width, and using the determined value of the capillary
pressure, channel dimensions, and sample velocity, the viscosity of the sample can be calculated.
The proposed design is supported through mathematical theory, and the supporting equations
have been previously used in the operation procedure of microfluidic viscometers. The device
proposed here will be fabricated utilizing a wet chemical glass etching method that has been
previously used in the fabrication of microchannels.
The selected design was chosen over an originally proposed device that operated on the
same principle but differed only in the number of channels and the microchannel geometry. Our
original design included only straight channels: two sets of closed channels; and two sets of open
channels identical in geometry to those of the closed channels but with two open ends. We chose
our optimal design over our original design since the use of serpentine channels of varied width
versus multiple straight channels allows us to decrease the size of the device and simplify the
procedure for device operation by using only one sample in the open channels. Additionally, the
use of fewer channels decreases the size of the blood sample needed from the patient.
A second alternative device was proposed based upon the phenomenon of electrowetting.
This alternative microfluidic device for measuring whole blood viscosity uses electrowetting as
the mechanism to facilitate the flow of the nonNewtonian blood sample. Electrowetting is a
phenomenon in which the application of an electric field alters the surface tension and essentially
pulls the droplet down onto the electrode, therefore decreasing the contact angle and increasing
the droplet contact area [12][13]. These changes in surface properties induce droplet motion. The
application of such an electric field can be utilized to drive a droplet of fluid through a
microfluidic channel. In a study by Lin, et al., electrowetting on dielectric (EWOD) is adopted to
drive liquids. Variously sized electrodes on a chip are employed to measure the velocity gradient
to determine the viscosity coefficient. The device is fabricated by microelectromechanical
system (MEMS) technology [14]. Based on theories regarding viscometry and electrowetting
described by Lin, et al., electrowetting on dielectric (EWOD) was chosen as the optimal method
of electrowetting for the purposes of this research. EWOD was used to drive the flow through
the channels of the device by altering the contact angle, surface tension, and the electron
distribution of the dielectric. The external force exerted by EWOD is:
(7)
2

εV
F ex = ΔpΔAcross = εo2d
ΔAcross
t

where ∆Across is the crosssectional area of the channel. In the linear channel, the viscosity
coefficient relates to the external force by:
(8)
x
F ex = S1ΔΔAcross = η( ∂v
∂y +

∂vy
∂x )ΔAtan

where ∆Atan is the tangent area in contact with the liquid and channel wall. A variety of physical
considerations influence equation 2 including channel size, dielectric constant of the material,
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thickness of the material, and size of the electrode. From equations 1 and 2, the linear channel
viscosity coefficient 
ηl
can be determined by:
(9)
η1 =

1

∂vx ∂vy
∂y + ∂x

εoεV 2 ΔAcross
2dt ΔAtan

Fig. 3.Top and crosssection view of the EWOD microfluidic device.
Based on the theory defined in Lin, et al., we composed this alternative design as
presented in Fig. 3, which displays a top view and a crosssection view. In our design we created
five separate channels so the blood viscosity of 5 different samples can be measured at a time.
The five blood samples can be pipetted near the inlet and the mechanism of electrowetting will
draw the sample into the channel. The crosssection view shows the various layers used to create
the electrowetting on dielectric device. In this design we are using barium strontium titanate
(BST) as the dielectric material as it has a high dielectric constant. The electrode surfaces are
coated with teflon which is hydrophobic in the absence of an electric field but becomes
hydrophilic when an electric field is applied.
Although this is plausible method for measuring viscosity, there is minimal literature on
the application of electrowetting for measuring nonnewtonian fluid viscosity. Therefore, we felt
that using electrowetting for measuring WBV would have required extensive background
research and experiments not feasible within the limited time frame we were given. In addition,
the fabrication method for creating a microfluidic device with electrowetting is complex and
requires processes and equipment which are not available to us, thus replicating these methods
would be difficult. Additionally, compared with the cost of our chosen design, electrowetting is
the more expensive option. Our chosen optimal design better satisfies the client objective of an
inexpensive device.
The final alternative design is an extension of previous work done by Kang et al.
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Fig. 4. Microfluidic device for measurement of whole blood viscosity designed by Kang et al.
[9].
The device utilizes a microfluidic channel array with two inlets for a blood sample and a
reference fluid of known viscosity. The sample and reference fluids are pumped via a syringe
pump into the microfluidic array at known flow rates Qspl and Qblood . Due to the fact that the
pressure drop across all of the channels is the same as a result of their identical dimensions, the
relative viscosity of the sample to the reference fluid may be calculated as:
(10)
μ
N Qref
μ = μspl
= Nspl
ref
ref Qspl
where μspl and μref are the sample and reference fluid viscosities, N spl and N ref are the number
of microchannels filled with the sample and reference fluids, and Qspl and Qref are the sample
and reference fluid flow rates. It can be seen from equation 6 that the unknown viscosity of the
blood sample may be calculated since the flow rates, reference fluid viscosity, and number of
filled microchannels are known.
While the described device provides a simple mechanism for the measurement of blood
viscosity, syringe pumps are both costly and have little portability. Here we propose the use of a
microfluidic gravity pump to move the fluid through the microfluidic array.
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Fig. 5. Gravity pump design using glass tubing as a fluid reservoir. Fluid enters microfluidic
array via silicone tubing [15].
Zhu et al. have developed a microfluidic gravity pump that delivers fluids at a consistent
flow rate (Fig. 5) [15]. The benefits of utilizing a similar design in place of a syringe pump as
applied to the microfluidic viscometer designed by Kang, et al. include increased portability and
cost efficiency of the device. This is particularly suited to the objectives set forth by our client.
We thus propose utilizing two gravity pumps with inlets as shown in Fig. 4, with an additional
two outlets at the corners of the reservoir depicted at the bottom corners of the device (Fig. 4).
The proposed device would be fabricated using the soft lithography method described in our
original device design.
While the device allows for the measurement of WBV over a clinically meaningful range
of shear rates, the simplicity and costeffectiveness of the device are limited by the incorporation
of gravity pumps. Ultimately, the chosen optimal device design was determined to best meet the
client’s objectives of simplicity, low cost, and portability.
2.2 Prototype
2.2.1 General Overview of Device
Microchannels:
The microfluidic rheometer design is composed of serpentine and sealed microchannels
of varying dimensions designed to measure WBV over a range of shear rates that is clinically
meaningful. Using the known values of the channel dimensions, the capillary pressure, and the
velocity of the sample traveling through the microchannels, the viscosity of the sample may be
calculated [1][2]. The overall device consists of two sets of serpentine open channels of varying
widths and two sets of closed channels. One set is used for the reference fluid of known viscosity
and the second set is used for the blood sample of unknown blood viscosity.
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Fig. 6
. Depiction of the open serpentine channels and closed channels of the device.
A schematic of the design of the device is provided in Fig. 6. The open serpentine channel is
shown at the bottom of the device, while the closed channels are shown at the top of the device.
The microchannels of the device are fabricated using a wet chemical etching method on glass
slides. The etched glass slides are bonded to a plain glass substrate using optical glue to
complete the device. The accuracy of the microfluidic rheometer was tested versus a parallel
plate rheometer. The device is simple to use, portable, operable in an oxygenated or a
deoxygenated environment, and costs approximately $1.40 per device. The proposed device is
novel as compared to other microfluidic viscometers in that it utilizes no external pumping
mechanism or power while providing a measurement of whole blood viscosity over a range of
shear rates found in the human body.
2.2.2 Subunits
Microfluidic Channels:
Description and Theoretical Justification:
Our device builds upon the research of Burns, et al. and Burns and Srivastava [11][16].
The device consists of four microfluidic channels: two identical sets of open serpentine channels
of varied width; and two identical sets of closed channels of widths identical to those of the
serpentine channels. To determine the unknown viscosity of a blood sample, both the sample
and a reference fluid of known viscosity need to be utilized. One set of each of the open and
closed channels are used with the blood sample and the reference fluid.
The fluid flow within microfluidic channels is characterized as laminar flow. Within the
channels of the microfluidic device fluid flows in parallel lines with no disruption between the
flow lines. All the layers of the fluid flow in a single direction with no perpendicular cross
current creating a smooth and orderly fluid flow. The force required to move a layer of fluid
against another is defined as dynamic viscosity. The measurement of dynamic viscosity obtained
from our microfluidic viscosity is based on the HagenPoiseuille law. The HagenPoiseuille law
describes the relationship between the pressure difference and fluid flow in a cylindrical tube
under steady flow conditions [18]. Fluid flow is defined by the following equation:
(11)
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Q =

ΔP *π*r4
8*μ*l

where ΔP is the pressure difference across the channel, r is the radius of the tube, l is the length
of the tube, μ is the fluid viscosity, and Q is the fluid flow. While the HagenPoiseuille law is
typically applied to Newtonian fluids, it has previously been established in research that this
equation may be extended to describe the behavior of nonNewtonian fluids such as blood in
microchannels [9][10][11][16]. Thus it may be assumed that the HagenPoiseuille law can be
extended to include nonNewtonian viscosity measurements using the microfluidic device
presented in Fig 6. In addition to the HagenPoiseuille law, a second mathematical model will be
applied to characterize the viscosity of whole blood using the proposed device. The power law
expression is a generalized Newtonian model which can be applied to a nonNewtonian fluid.
The power law expression is defined by the following equation:
(12)
η = m * ẏn−1
where η is the nonNewtonian viscosity, m is a constant characterizing the fluid, ẏ is the shear
rate and n is a constant which characterizes a fluid as either shear thinning or shear thickening
[16]. The combination of the power law expression and the HagenPoiseuille law provides the
complete mathematical model for the measurement of nonNewtonian viscosity utilized in the
proposed optimal design.

Fig. 7.
Open serpentine channel configuration.
The open channel segments of varied widths (Fig. 7) allow for more clinically
meaningful data by enabling the measurement of blood viscosity over a range of shear rates
present in the human body. Additionally, by fabricating one channel of varying width versus
multiple channels, a smaller blood sample may be used.
Our device uses the physical phenomenon of capillary pressure to drive fluid flow
through microfluidic channels. This option facilitates the construction of a microfluidic device
14

that requires no external pumping mechanism or energy source and is thus an ideal choice to
meet the objectives of portability and costefficiency established by our client. The capillary
pressure in a microfluidic channel is governed by the channel geometry, the contact angles of the
fluid against the channel walls, and the surface tension of the fluid. This relationship may be
described mathematically via the following equation:
(13)
cosθ +cosθ
cosθ +cosθ
P c =− γ( bh t + lw r )
where P c is the capillary pressure, γ is the surface tension of the fluid, h is the height of the
microchannel, w is the width of the microchannel, and θb , θt , θl , and θr are the contact angles
of the fluid on the bottom, top, left, and right channel walls, respectively [17]. It may be seen in
equation (13) that the capillary pressure is independent of the length of the microchannel. This
fact was exploited in our design, allowing us to use a single open serpentine channel of varying
widths for viscosity measurement while using shorter channels of varied widths to separately
determine the capillary pressure of the open channel needed for calculation of viscosity.

Fig. 8.
Closed channel configuration.
The capillary pressure of both the sample and reference fluids is calculated using the
closed channels shown in Fig. 8. The fluid is applied at the inlet of each of the closed channels.
One set of channels is used for the blood sample, and the other identical set of channels is
utilized with the reference fluid. According the the ideal gas law, here the capillary pressure may
be determined by:
(14)
V
P capillary = P atm( V 12 − 1)
where P atm is the atmospheric pressure, V 1 is the volume of air originally in the channel, as
calculated using the channel dimensions, and V 2 is the volume of air in the channel after the
sample is added, calculated from the location of the airfluid meniscus and the channel
dimensions. The samples are then applied to the inlets of the open channels. The viscosity of
the unknown sample is equal to:
(15)

2

η = ds

1 ΔP
vL

2+ 1
3 3n

where ΔP is equal to the capillary pressure of the blood sample, and the other variables are
calculated as follows:
15

●

d2
s

vL

calib
= μcalibP capillary,calib
, where μcalib is the known viscosity of the reference fluid, Lcalib is the

length traveled by the reference fluid in the open channel, v is the velocity of the
calibration fluid in the open channel which is equal to Lcalib divided by the time for fluid
travel, and P capillary, calib is the capillary pressure of the calibration fluid, calculated using
equation 4;
● L is the length of the blood sample in the open channel;
● v is the velocity of the blood sample in the open channel, equal to Lt , where L is the
length of the blood sample in the open channel and t is the time for the sample to travel
the length L;
● n is found from a loglog plot of L1 vs. velocity (v). The value of n is less than 1 for shear
thinning fluids and greater than 1 for shear thickening fluids.
Deoxygenation Chamber:
Description and Theoretical Justification:
When measuring the WBV of blood samples taken from SCD affected patient a
deoxygenation chamber is used to observe the sickling behavior of red blood cells under
deoxygenated conditions. The deoxygenation chamber will be used both while using the
microfluidic device and with the conventional parallelplate rheometer to confirm the accuracy
of viscosity measurements. The deoxygenation chamber is shown in Fig. 9. There are two top
cover components which can be used with the chamber. One is a split cover with a circular
opening in the center which is to be used with the parallel plate rheometer and the other is a solid
cover to be used with the microfluidic device.

Fig. 9. Exploded view of the deoxygenation chamber design. Split cover is shown to the upper
right, the wall section if shown in the middle, and the solid cover is shown to the lower left.
16

The sides of the chamber are constructed from polycarbonate (PCB) tubing. The top and bottom
portions of the chamber are constructed from PCB sheeting. As previously stated the chamber
has one split and one solid cover. The split cover has a hole in the middle when the two halves
are joined. This allows the cover to be placed around the shaft of the parallelplate rheometer
geometry to best seal out the oxygen from the surrounding environment. The halves of the split
cover secure into the cylindrical portion of the deoxygenation chamber and the solid cover also
seals the chamber in a similar way. The PCB material used to manufacture the chamber has low
bioreactivity and low reactivity with nitrogen, thus maintaining the deoxygenation of the blood
samples.

Fig. 10.
Rheometer used in combination with deoxygenation chamber.
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2.2.3 Fabrication Protocols
Protocol: Photoresist Masking of Slides
Materials and Equipment:
● spin coater
● Fume hood
● Photomask (500 dpi resolution)
● Mask aligner/UV light source
● Precleaned glass slides
● PR4000A photoresist (Futurrex, Inc.)
● RD6 photoresist developer (Futurrex, Inc.)
● Tray or pan for developing
● Hot plate
● Distilled water
1. Set the hot plate to 90℃
2. Place a glass slide onto the spin chuck of the spin coater and vacuum. Spin by hand to
ensure that the slide is centered.

Fig. 11. Spin coater used to coat glass slides with an even layer of photoresist. 
(image:
www.deanlab.com)

3. Program the spin coater to an initial step of 300 rpm for 5 s followed by a second step of
500 rpm for 20 s. Perform a trial run to ensure that the program is working properly.
4. After ensuring correct operation of the spin coater, pour enough photoresist onto the slide
to coat it. Be sure to pour photoresist along entire length of the slide.
5. Close the lid of the spin coater and run.
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6. When the spin coater is finished, open the lid quickly to avoid drips onto the slide. Turn
off the vacuum, remove the slide and bake on the hot plate at 90℃ for 10 minutes.
Remove from hot plate and cool. Increase the temperature of the hot plate to 100℃.
7. Align the photomask over the slide using the mask aligner.

Fig. 12
. Mask aligner used for proper positioning of photomask during UV exposure.
(image: 
www.nanoqam.uqam.caimagesdevices36
)

8. Expose the slide to UV light for 10 s.
9. Immediately following UV exposure, bake the slide for 3 minutes at 100℃ on the hot
plate. Remove from hot plate and cool. Increase the temperature of the hot plate to
130℃.
10. Place the slide into the tray or pan and add and amount RD6 developer sufficient to
cover slide. Gently swirl for 3.5 minutes.
11. Remove slide and rinse with distilled water. Rinse the tray with distilled water and empty
into the proper disposal container.
12. Bake the slide on the hot plate at 130℃ for 90 minutes. Remove and cool.
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Fig. 13. Clean room facility in which the slides are spin coated, UV exposed, and developed.
(image: 
www.biotech.uconn.edu
)

Protocol: Wet Chemical Etching of Glass Slides
DANGER: Use of hydrofluoric and hydrochloric acid may result in severe injury and/or death.
Proper training of personnel handling these materials is necessary. Acids must be handled only
under a fume hood. Avoid breathing vapors as they may be lethal. A hydrofluoric acid spill kit
including calcium gluconate gel should be on hand when using this protocol.
Materials and Equipment:
● Fume hood
● Nalgene beakers, 600 mL (5), 500 mL (1), 100 mL (2)
● Graduated cylinder
● Polyethylene tweezers
● Glass slides
● Distilled water
● Hydrofluoric acid
● Hydrochloric acid
● Acetone
1. Place one photoresistmasked slide photoresist side up in the bottom of each of the four
600 mL Nalgene beakers and place in the fume hood.

20

Fig. 14
. Placement of photoresistmasked slide in Nalgene beaker for etching.
2. Using the graduated cylinder, measure 80 mL distilled water and pour into the 500 mL
Nalgene beaker and place in the fume hood.
3. Pour approximately 300 mL of water into a 600 mL Nalgene beaker and place in the
fume hood. This may be used for the disposal of waste acid if necessary.
4. Working under the fume hood, measure 20 mL of hydrofluoric acid into a 100 mL
Nalgene beaker. If necessary, pour excess slowly into the 600 mL beaker containing the
~300 mL distilled water. Slowly pour the 20 mL of hydrofluoric acid into the 500 mL
beaker containing the 80 mL distilled water.
5. Working under the fume hood, measure 40 mL of hydrochloric acid into the second 100
mL Nalgene beaker. If necessary, pour any excess slowly into the 600 mL waste beaker.
Add the 40 mL hydrochloric acid slowly to the 500 mL beaker containing the distilled
water and hydrofluoric acid.

Fig. 15.
. Pouring of acid into distilled water to prepare etching solution.
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6. Carefully pour the etching solution over the glass slides in the 4 600 mL Nalgene
beakers, dividing the solution approximately equally. Ensure that the solution is covering
the slides as shown in Fig. 16. Gently swirl the beakers to get the slides to sit on the
bottom if necessary. The solution will etch the glass at a rate of ~0.65 μm/minute. Here,
an etching time of 46 minutes is used to attain a theoretical channel depth of ~30 μm.

Fig. 16. Slide to be etched covered in etching solution. Approximately 35 ml of etching solution
is used per slide.
7. Rinse the 100 mL and 500 mL Nalgene beakers with distilled water, disposing of the
excess in the 600 mL waste beaker. Empty the waste beaker into the proper container
between rinses if necessary, adding more distilled water to the beaker for disposal after
emptying. Rinse the 600 mL beaker with distilled water.
8. Wash the distilled waterrinsed 100 mL, 500 mL, and waste beakers in the sink and let air
dry.
9. Before removing the etched slides from the solution, fill the 500 mL Nalgene beaker with
sufficient distilled water to cover slides and place in the fume hood. Prepare the waste
beaker, adding ~300 mL distilled water to the 600 mL Nalgene beaker and place under
the fume hood.
10. Remove the etched slides with the polyethylene tweezers and place into the 500 mL
beaker to soak. Rinse the tweezers in the 500 mL beaker.
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Fig. 17. Removing etched slide with polyethylene tweezers and slide soaking in beaker of
distilled water to rinse.
11. Dispose of the etching solution in each of the 600 mL beakers by slowly pouring into the
waste beaker. Empty the waste beaker as necessary, refilling with distilled water.
12. Remove slides from distilled water rinse and dry on a paper towel.
13. Rinse all beakers with distilled water.
14. Wash beakers in sink and let air dry.
15. Remove any remaining photoresist from slides using acetone and rinse with distilled
water.
Note: This protocol provides etchant sufficient for four glass slides. Reagent amounts may be
adjusted as necessary in a 4:2:1 ratio of distilled water:hydrochloric acid:hydrofluoric acid.
Protocol: Bonding Etched Slides
Materials and Equipment:
●
●
●
●

UV glue, Lens Bond Type SK9, 40 cps (Summers Optical)
UV light source
Etched slide
Precleaned glass slides
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1. Place 3 drops of glue on one plain glass slide. This slide will be used only to aid in the
even distribution of glue onto the slide to be bonded to the etched slide. Place a second
glass slide onto the first slide. This will cause the glue to spread into a thin layer between
the slides.
2. Remove the top slide by gently sliding it sideways off of the other slide.
3. Starting at the end of the etched slide opposite the inlet of the channels, gently place the
gluecoated slide on top of the etched slide. Push the slide gently towards the inlets of
the channels, ensuring that the only inlets remain open and that the plain slide covers the
remainder of the etched channels. Ultimately, the slides will be staggered on top of one
another as shown in Fig. 18.

Fig. 18. Alignment of the etched and plain slides during bonding. The plain slide is positioned
such that only the inlets of the channel are not covered.
4. Inspect channels to ensure that the glue surrounds all areas and is not blocking any of the
channels. Gently press on any areas in which the glue has not appeared to have travelled.
Blocked channels will have portions that are not visible; this is where glue has filled the
channels. If necessary, remove the top slide, clean off the glue with acetone, and repeat
the process.
5. Once satisfied that the glue is properly distributed, place the device under the UV light
source for one hour to complete bonding. The UV light source should be approximately
1 in. over the device.
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2.2.4 Operation of Device
Each completed device consists of two serpentine microchannels etched in glass and two
sets of five microchannels in a closed channel configuration. One accessory which can be used
with the device is a deoxygenation chamber.

Fig. 19.
Open serpentine microchannel. Each complete device includes of two of the channels

pictured.

Fig. 20. One microchannel of the closed configuration. Each device includes two sets of five
closed microchannels of varied width.
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Fig. 21.
Deoxygenation chamber shown with solid cover.

Fig. 22. 
Deoxygenation chamber shown for split cover suitable for use with a conventional
parallelplate rheometer.
Operation of Deoxygenation Chamber with Microfluidic Device:
The deoxygenation chamber is to be used with the inverted microscope and the
microfluidic device. Saran wrap is placed on the microscope stage and the microfluidic device is
placed on top of the saran wrap. The chamber is placed over the channel and the saran wrap is
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pulled up and secured with a rubber band to complete the seal. Tubing connected to an external
nitrogen tank enters the chamber and rapidly releases nitrogen gas. The gas displaces the oxygen
creating a deoxygenated environment.
Operation of Deoxygenation Chamber with Parallel Plate Rheometer:
When the chamber is utilized with the parallelplate rheometer, the split cover is used.
First the cylindrical portion of the chamber is placed on the base of the rheometer. The blood
sample is placed, then the parallel plate geometry of the rheometer is lowered. Finally, the split
cover is secured around the shaft of the geometry. There will be tubing which enters the chamber
to maintain the deoxygenation condition. When used with both the rheometer as well as the
inverted microscope, the blood sample is initially deoxygenated in a separate facility before the
use of the chamber. Once the sample is in the chamber, the deoxygenation of the sample is
maintained through an influx of nitrogen introduced to the chamber. The nitrogen gas displaces
the oxygen creating a deoxygenated environment. While some small leaks will likely occur due
to the necessary split in the cover that allow the rheometer geometry to rotate freely, the positive
pressure of the nitrogen used to deoxygenate the chamber will keep to a minimum the
environmental oxygen entering the chamber through any small gaps.
Operation of Microfluidic Rheometer:
Closed channels
Materials and Equipment:
●
●
●
●
●
●

Microchannels of closed channel configuration
Reference fluid of known viscosity (distilled water is suggested)
Blood sample
Pipette
Microscope
Ruler

1. Place the glass slide containing the closed channel under a microscope.
2. Pipette 10ul of reference fluid and place at the opening of the closed channel.
3. Wait for the reference fluid to stop moving within the channel.
4. Measure the length of the distance the sample moved within the channel.
5. Repeat the measurements for each of the 4 remaining closed channels. These
measurements will be used to calculate the capillary pressures for each of the varied
channel widths using equation
6. Repeat this process with 10 μl of blood.
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Serpentine Channels
Materials and Equipment:
● Serpentine microchannels
● Reference fluid of known viscosity identical to that used with closed channels
● Blood sample
● Pipette
● Timer
● Ruler or other means of measurement such as imaging software
1. Place 10 μl sample of blood at the inlet of the serpentine channel with the smallest width
and immediately begin recording the time using the chosen timing method.
2. Note the position of the meniscus of the fluid sample and the corresponding times at
various lengths of travel through the serpentine channel.
3. These measurements will be used in the calculation of viscosity and each represents a
different shear rate. The number of points and location are determined by the user. The
greatest shear rates occur immediately after the sample is placed and the lowest as the
fluid travels towards the end of the channel.
4. Repeat the process using the reference fluid.
Note: The value of the reference velocity multiplied by the length travelled in the channel should
be roughly the same for all positions. It is recommended
to take an average of these values and
d2
insert for the value vLcalibration used to calculate the S term of equation 15.
Calculation of Blood Sample Viscosity:
The data obtained using the protocols for testing with the closed channels and serpentine
channels is used for the calculation of the unknown blood sample viscosity using equations 14
and 15 as described in section 2.2.2.
The experimental procedures used to measure the lengths and times associated with the
progression of the sample fluids through the microchannels are ultimately determined by the user
and may take into account the number of desired data points as well as the range of shear rates at
which the viscosity is to be calculated. An overview of the experimental procedure utilized for
the testing in this research is presented here as a suggestion for a potential testing protocol.
However, experimental setups are not limited to those described here.
Comparison of Data:
After fabrication of the device, a comparison of the device performance versus that of a
conventional parallelplate rheometer was made to determine the accuracy of the microfluidic
rheometer. It was shown here that the data produced using the fabricated device indicated
correlation with data acquired using the conventional rheometer as shown in Fig. 23.
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Fig. 23. Viscosity vs. shear rate for measurements made using the microfluidic device and a
parallelplate rheometer shown in orange and blue, respectively.
The outliers seen in the data correspond to the most narrow portion (200 μl in width) of
the open serpentine channel. This may be due to the width of the channel being too narrow to
allow for nonturbulent flow of the liquid sample. Future serpentine channel designs should
incorporate widths between 200 μl and 350 μl to determine the minimum threshold of
nonturbulent flow. The shear rates produced by the device range from ~150 s−1 to 350 s−1 .
Because blood is a nonNewtonian fluid that exhibits shear thinning, viscosity decreases as
shear rate increases until a steady consistency is obtained. Within the human cardiovascular
system, human blood viscosity remains approximately constant as shear rates increase above 300
s−1 due to the fact that above this shear rate, blood plasma dominates the behavior of whole
blood. As shear rates decrease below 300 s−1 , however, human blood viscosity increases
exponentially as the interactions between red blood cells dominate the behavior of whole blood.
Future work would involve increasing the total length of the serpentine channel to expand the
shear rate range produced by the device. Due to an inverse relationship between shear rate and
vessel diameter, the largest vessels in the body (e.g. aorta) exhibit low shear rates and the
smallest vessels (e.g. capillaries) exhibit high shear rates. To obtain a shear rate range that is
even more clinically meaningful, the minimum shear rate should be around 20 s−1 to better
mimic the shear rates experienced in the largest vessels of the body.
Optional/Additional Equipment:
Digital camera:
In this research, a digital camera was used to image the sample fluids in the device. We
had limited time for fabrication of devices due to obstacles encountered during the design
process and thus wanted to record testing to ensure a maximum availability of data for analysis.
In this setup, we used a digital camera with a macro lens and manual focusing capability with the
ability to record video.
The digital camera should be placed above the device at a height that allows for the
channels to be clearly observed and in focus.
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Fig. 24. 
Casio EXILIM Pro EX‑F1 6.0 MP Digital Camera secured at proper height above
device.
To focus the camera, the mode is set to “macro” and “auto focus” is turned off. When
recording a video, the timer is set to 10 seconds to allow for sufficient time between beginning
the recording and ejecting the sample from the pipette. Additionally, it is important to prevent
too much light exposure as this may interfere with the quality of the video or image. It should be
noted that the digital camera is highly sensitive to subject distance and light exposure and it may
require several attempts to obtain a focused image. The sample is ejected and allowed to travel
the entire length of the channel prior to stopping the video. Postrecording, video and images
may be analyzed using image processing software. The known channel widths may be used to
set the length scale of the obtained images and video, enabling the determination of the distances
travelled by the sample fluids within the channels. Noting the time corresponding to particular
frames, it is possible to determine the velocity of the fluid through the channels. In the
experimental testing done during this research, Matlab was utilized for video analysis while
Image J was used for the analysis of still images.
Microscope
:
To observe the channels and fluid within the channels at a microscopic level, it is
important that the device is properly placed on the stand of the microscope of choice. If a
confocal microscope is used, the device should be placed on the stand and positioned using the
x and yaxis knobs such that the area of interest appears on the monitor.

30

Fig. 25.
XY translation mechanical stage of confocal microscope with XY translational
control knobs. 
(image: http://micro.magnet.fsu.edu)
In this research, Image J was used in conjunction with a confocal microscope. Using this setup,
images can be taken by leaving live view in the software and selecting “snap.” To enter live
view again, select “live.” If a brightfield microscope is being used to observe the device, it is
recommended that the lenses are switched to darkfield to provide greater contrast resulting in a
more distinct visualization of the channels. It was found here that using the microscope only
provided a limited field of view and that it was not possible to image the entirety of the channel
at one time. Therefore, the microscope was most useful for viewing the fluid in the closed
channels as this fluid does not move continuously, unlike fluid in the serpentine channels. The
microscope, however, is wellsuited for characterizing the qualities such as smoothness,
continuity, etc. of fabricated microchannels.
Pipette:
Here, a pipette holder was assembled using Thor components and mounted on a Thor
optical table. The setup incorporated micropositioners for accurate and stable placement of the
pipette tip at the inlet of the microchannels during testing and filming.

Fig. 26.
Pipette holder in which pipette is properly placed.
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The purpose of the pipette holder is to stabilize the pipette so that a wavering tip, which may
distort image clarity, is not apparent in the video recordings. The pipette tip must be changed
between samples to avoid crosscontamination which may alter results. Pipette tips should be
properly disposed of in a biohazard sharps bin. To change the pipette tip and reload with sample
in the shown setup, the pipette must be removed from the holder and replaced prior to the
subsequent test. In addition to proper placement within the pipette holder, the pipette must also
be properly placed at a sufficient height and distance from the channel inlet. Sufficient space
between the pipette tip and channel inlet allows for the sample droplet to fall out of the tip
immediately onto the inlet and drawn in instantaneously. It should be noted that not all of the
sample liquid will be drawn into the channel allowing for excess fluid to run down the side of the
device and seep into an adjacent channel causing contamination and rendering it potentially
unusable. To prevent this from occurring with the serpentine channels, it is recommended that a
small piece of tape be placed on both sides of the channel inlet to restrain the droplet from
sliding along the device. It was also found that cutting channels apart after etching is another
feasible alternative to prevent this issue.
3.
Realistic Constraints
3.1 Clientstated constraints
Portability: The client has indicated the importance of the device being portable. Ideally, the
device should be operable outside of a hospital or laboratory setting, such as in the field. It is not
necessary that the deoxygenation chamber be portable.
Cost:
The device should be of low cost to manufacture.
Simplicity: 
The client has indicated that the device should be simple in both design and operation
such that it is easy to construct and little training is required to use the device.
Operability: The device should be operable under both oxygenated and deoxygenated conditions.
The client’s current laboratory setup uses nitrogen as a means to maintain a deoxygenated
environment when working with SCD RBCs. Thus, the materials utilized for the construction of
both the rheometer and the deoxygenation chamber must be compatible with nitrogen.
3.2 General constraints
Environmental: Experimental preparation is conducted within a sterilized cell hood to avoid
contamination of blood samples from bacteria, random particles, etc. due to lab environment
exposure. This careful precaution also serves to limit contact between blood samples and the
general lab area thus protecting the lab itself and all lab personnel from exposure to bloodborne
pathogens. The materials used for the manufacture of the device are disposed of according to
University of Connecticut Environmental Health and Safety protocols. Proper handling
procedures are followed for handling of chemical and biological agents and for any materials for
which previous protocols did not exist the Division of Environmental Health and Safety at the
University of Connecticut was consulted. All group members will receive Lab Safety and
Chemical Waste Management training, BiosafetyGeneral training, and Bloodborne Pathogens
training through the Division of Environmental Health and Safety.
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Manufacturability: The microfluidic devices used to conduct these studies were manufactured
inhouse when possible. The client provided laboratory space when possible while some
procedures such as spin coating, photoresisting and etching were done in other laboratories
within the University. For the construction of the deoxygenation chamber, the machine shop at
the University was used and provided the necessary equipment for the construction of the
entirety of the design. Group members received Machine Shop Safety training as required by the
University of Connecticut prior to using the machine shop equipment. In terms of commercial
production, if the viscometer design is to be fabricated on a large scale the microfluidics platform
offers a cost effective means to do so [17]. Wet chemical methods similar to that used for the
etching of the microchannels are used for manufacture of circuit boards and demonstrate the
scalability of the process to a commercial level. Additionally, the deoxygenation chamber
design is suited for scale up as it is composed of relatively few parts. The design of the
PCBconstructed portions of the chamber could easily be made via injection molding, also
adding to the ease of scaleup.
Sustainability: With proper care, the closed channels of the microfluidic devices involved in
these studies are capable of being reused. Due to the nature of the design, the serpentine
microchannels are not reusable. The device, however, is designed to be as compact as possible
and to produce the minimum amount of waste while meeting the objectives of the project.
Ethics: The project held a limited budget. To conserve funds, parts were developed inhouse
whenever possible. While additional supplies were needed, thorough research was conducted
prior to purchasing to assure utmost reliability, effectiveness and costefficiency. All funds used
were solely for the purposes of this research. The client was kept updated on budget planning
and consulted prior to any deviations from the planned use of funds. The potential applications
of the device to healthcare in areas of limited income was kept in mind during the design process
and the projected commercial cost of the final device was accordingly kept to a minimum.
Health and Safety: All group members will have undergone biological and chemical lab safety
training prior to working in the lab. Microfluidic devices, rheometer components and anything
else that comes in contact with the blood samples were be properly cleaned after every
experiment.
Political and Social: To our knowledge, there are no political or social constraints on the project
at this time.
4.

Safety Issues
Individuals working with the device or manufacturing the device may potentially be
exposed to hazardous chemicals or biological pathogens. Manufacturing of the device includes
the use of chemicals that may be harmful to the health of personnel. The protocol for the
photoresist masking of slides calls for the use of chemicals such as RD6 developer and
PR4000A photoresist that may cause skin and eye irritation. With the fabrication process
exposure to the RD6 developer and PR4000A photoresist is minimal. Through the use of
personal protective equipment such gloves and goggles exposure to these harmful chemicals can
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be minimized. Further, these chemicals are only used in a hood to further minimize exposure to
personnel.
The wet chemical etching process used to create microchannels in glass slides requires
the use of hazardous chemicals such as hydrofluoric acid and hydrochloric acid. Both of these
reagents have the potential to cause serious injury or death. They should be handled with
extreme caution within an appropriate fume hood only. Users should wear adequate personal
protective equipment including laboratory coats, goggles, and two pairs of gloves. A
hydrofluoric acid spill kit containing calcium gluconate gel should be immediately on hand in the
case of environmental or human exposure. Individuals handling these chemicals should be
familiar with the hazards and should have undergone the appropriate chemical safety trainings as
required by their institutions. Upon completion of use of the reagents, they should be properly
disposed of according to regulations.
When bonding the etched slides to a clean glass slide there is exposure to possible
hazardous fumes from the glue. The optical glue is composed of methacrylate and UV resins.
During application there are fumes released. These fumes are not toxic with minimal exposure
but, long term exposure is harmful. It is important to work in a well ventilated facility when
using the optical glue.
Individuals working with the completed device will come in contact with biological
samples, and therefore are at risk of being exposed to possible pathogens. However, the user of
the device is never directly in contact with the blood sample. The blood sample is transferred
using a pipette from one closed container to the inlets of the device where the sample is drawn
into the channel. In addition, the device requires only a dropletsized sample to function, so a
simple needle prick to the finger will suffice to obtain the blood sample. With such a small
sample the exposure to blood is minimized, thus the risk of contracting any blood borne
pathogens is reduced. While the risk of exposure is small, universal precautions should still be
taken and the proper personal protective equipment utilized.
5.

Impact of Engineering Solutions
WBV is recognized as an indicator of health in various disorders including cardiovascular
disease and SCD [1][7]. Cardiovascular disease is a group of diseases that includes coronary
heart disease, deep vein thrombosis, and peripheral arterial disease [8]. According to the World
Health Organization, more people worldwide die annually from cardiovascular disease than from
any other cause, a trend that is expected to continue in the future [8]. More than 80% of these
deaths occur in low and middleincome countries [8].
SCD is a blood disorder in which the body makes blood cells that become crescent
shaped when deoxygenated as opposed to maintaining the biconcave shape of healthy cells.
Individuals affected by the disease experience a range of symptoms such as chronic pain,
necrosis, and stroke [3]. It is estimated that the disease occurs in >200,000 births per year in
Africa and between 60,000 and 100,000 births per year elsewhere [2].
It has been shown that WBV is generally higher in patients with cardiovascular disease or
SCD. It is clear that measurement of WBV is of clinical importance to better assess the health
of patient. Our optimal design provides an effective solution in that it allows for quick, simple
measurement of WBV using a small sample of blood. Additionally, the prevalence of diseases
affecting blood viscosity in low and middleincome countries that may not have widespread
access to laboratory facilities makes desirable a device that can be utilized in the field. While
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other research has been done on the measurement of WBV, the construction of such devices
limits their applicability outside of a hospital or laboratory setting. The device by Kang, et al.,
allows the measurement of WBV at any desired shear rate, but utilizes a pumping mechanism
that limits the simplicity, portability, and costeffectiveness of the device [10]. Srivastava, et al.,
demonstrate a device that uses no external pump but that is limited to a low range of shear rates
as determined by the viscosity of the tested sample [11][16]. Our design provides a novel
engineering solution in that it facilitates the measurement of WBV over the range of shear rates
present in the human body without the use of an external pumping mechanism. These qualities
contribute to the applicability of the device as a pointofcare measurement for individuals with
conditions affecting WBV that may not have regular access to medical care. The low cost,
portability, simplicity, and practicality of our device have the potential to benefit clinics around
the world, while the applications of the device can yield meaningful data that can positively
impact public health by means of early diagnosis, prognosis, and disease prevention.
6.

LifeLong Learning
At the conclusion of this project, team members have acquired a variety of skills that are
relevant to industry and academia and are translatable to their future pursuits. First, the wet
chemical glass etching process utilized to create the microfluidic devices is a valuable technique
that has been introduced to us. This process involves a variety of materials such as PR4000
photoresist and RD6 developer to mask a glass slide prior to etching with a solution of
hydrofluoric acid, hydrochloric acid and distilled water to form microfluidic channels. We also
learned how to bond etched slides to plain glass using optical glue cured with UV light. In
addition to these materials, we have been introduced to other devices and techniques that play a
role in the etching process. We were familiarized with the operation of the equipment in the
Chemistry Clean Room at the University of Connecticut including a spin coater, UV light source
and mask aligner. We also underwent the appropriate trainings to handle chemicals as well as
biological samples.
To create the mask applied when exposing UV light to specific regions of PR4000
photoresist, the design software SolidWorks is utilized. This program is an important tool as it
played a vital role in the development and success of our design. Furthermore, as a means for
creating clear and effective schematics, SolidWorks greatly assisted in the the overall
presentation of our final product. We have also learned how to use a rheometer to measure the
viscosity and shear rates of our samples. The rheometer provided measurements to be used as
our standard comparison. Associated with the rheometer are the data acquisition and analysis
programs which are essential skills that have also been acquired. Moreover, the rheometer and
associated computer software depend on the geometry used during testing. There exist a variety
of geometries such as a flat surface geometry and coneshaped surface geometry that we have
been made aware of, although only the flat geometry was used in our studies.
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7. Budget
Item

Company

Total ($)

Balance ($)

PEO

Sigma Aldrich

44.88

955.12

Mask 1

CAD/Art Services

63.50

891.62

HCL

Sigma Aldrich

276.86

614.76

HF

Sigma Aldrich

Glass slides

Sigma Aldrich

Acetone

Sigma Aldrich

Positive Photoresist

Futurrex, Inc.

383.00

231.76

Developer

Futurrex, Inc.

UV lamp

Summers Optical

204.00

27.76

Optical Glue

Summers Optical

88.00

60.24

PCB

MCMasterCar

38.94

99.18

Mask 2

CAD/Art Services

38.50

137.68

Deoxygenation
Chamber

Machine Shop:
UConn

25.00

162.68

Spill Kit

Calgonate Inc

361.00

361.00

Beakers

Chemistry building
Stores

41.28

41.28

1564.96

Over Budget
by $564.96

Total

8. Team Member Contributions to the Project

The work completed on this project was accomplished as a team in a manner that was fair
and equal among the members. Throughout the course of the project, projectspecific tasks were
divided up and assigned to individual team members, either by the client or the team itself, or
performed together as a team. All tasks were carried out effectively and efficiently by the
members of the team. Specific contributions to the project by each team member will now be
elaborated upon.
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Catherine contributed to the project by attending training sessions regarding lab safety,
rheometer testing and software analysis as well as microchannel fabrication by means of soft
lithography. She also assisted in the completion of preliminary tests with the rheometer using
ketchup as the fluid under observation. Catherine contributed to the theoretical development of
the alternative designs involving electrowetting to create a microfluidic device. Once the
optimal design was selected, she then worked with SolidWorks to assist in the creation of a
3dimensional schematic of the preliminary device. Catherine also worked with Matlab to
determine the range of shear rates that this device would be capable of producing with varying
dimensions. Throughout the first semester, Catherine completed her assigned portions of the
project reports and weekly meeting presentations and always made sure to complete her tasks on
time and to the best of her ability.
Catherine continued to work diligently throughout the second semester. She took part in
the purchasing of all new laboratory and safety materials for glass etching and was actively
involved in the fabrication of microchannels using this new technique. Catherine also worked in
the clean room to spincoat and develop many channels using photoresist and developer,
respectively. Upon fabricating testable devices, Catherine dedicated several hours to learning
how to properly focus and record a video of the sample fluids traveling through the channels.
Subsequent to testing, she assisted in the completion of data analysis. Throughout the second
semester, Catherine contributed by completing equal portions of the project and project reports.
Jessica contributed to the project by attending trainings including sessions on Lab Safety
and Chemical Waste Management, microfluidic fabrication methods, blood sample preparation,
and rheometer operation.
With other teammates, she performed experiments with
nonNewtonian fluids with a parallelplate viscometer. Jessica contributed to the project through
research on topics including rheology, SCD, cardiovascular disease, nonNewtonian fluids,
cardiovascular shear rates, capillary flow, and microchannel surface modifications. She also
researched previous work on similar devices done by others. Jessica contributed ideas to the
final design of the microfluidic viscometer and designed the deoxygenation chamber. She also
gained experience with Solidworks and modeled the deoxygenation chamber using this software.
Jessica also contributed to the weekly presentations and in the writing of project reports.
Jessica contributed throughout the second semester of the project by working with her
team members to fabricate and test the device prototype. Tasks included ordering supplies, spin
coating and developing glass slides in the clean room, chemical etching of microchannels and
bonding of channels with optical glue. Additionally, Jessica assisted in the testing of the
fabricated device that involved filming and data analysis as well as comparative testing made
with a parallelplate rheometer.
During the first semester Divya contributed to the project by initially conducting
preliminary research on the concepts of rheology, nonnewtonian fluids, microfluidics and
rheometer. She later than conducted a thorough review of papers by Srivastava and Burns which
was used to developed our final device design. Divya learned the basics of solidworks to create
the design of the device on solidworks and also produce the mask design required for the
fabrication process. With her other teammates, Divya participated in learning and conducting the
fabrication of the device using soft lithography. Towards the end of the fall semester, She
attended the required machine shop training and conducted preliminary test of the device was
fabricated using soft lithography.
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During the spring semester Divya researched and learned the new fabrication method of
wet chemical etching. She assisted with the purchasing of all the new materials and maintaining
an accurate account of all the purchases. Her biggest contribution was working on the
photolithography process of the wet chemical etching method which consist of spin coating, UV
exposure, and developing. She worked on fine tuning the details of the method such as baking
time and exposure time to produce the best result. She also assisted with chemical etching and
bonding process. Towards the end of the semester she worked on testing device and analyzing
the data using Image J and Matlab.
9. Conclusion
As previously stated, SCD impacts hundreds of thousands of people worldwide causing
patients to experience a range of symptoms such as chronic pain, frequent infections, necrosis,
organ damage, and stroke [3][4]. Furthermore, our client’s current work involves research on
SCD, which is known to affect WBV. While WBV is recognized as a pointofcare
measurement in SCD and other diseases affecting WBV such as cardiovascular disease, current
testing methods involve expensive equipment, are time consuming, require a large blood sample
on the order of milliliters, and are not practical outside of a laboratory setting [5][6][7][9]. This
may present a barrier to treatment, particularly in those areas in which individuals do not readily
have access to healthcare and/or medical facilities.
The goal of this project was to design, fabricate, and assess the performance of a simple,
inexpensive, portable device for the measure of WBV. Taking into account the client’s
particular interest in measurements of blood viscosity in SCD, the device was designed to
function in both an oxygenated and deoxygenated environment. A microfluidic viscometer using
capillary pressure to drive the flow of a reference fluid and a blood sample through an array of
both open serpentine microchannels and closed microchannels was fabricated. The closed
channels of the device allow the calculation of capillary pressure using the reference fluid while
the serpentine channels are used to calculate parameters including fluid velocity that are used in
the final calculation of the WBV of the sample. The device was tested and the results compared
with a parallelplate rheometer. 
The viscosity measurements made with the fabricated device
indicated a correlation with those made using the conventional rheometer.
The proposed device overcomes limitations of currently available viscometers and allows
for operation outside of a laboratory setting. It offers the novelty of portability, simplicity, and
the measurement of WBV over a range of shear rates while meeting objectives specified by the
client with a projected cost of ~$1.40 per device.
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12. Appendix
12.1 Updated Specifications
Microfluidic Device
To produce the microfluidic device we will be using a glass etching method.
Material Specifications:
Physical:
Glass
Environmental:
Storage Temperature: 25
℃
 55
℃
Operating Temperature: 25
℃
 55
℃
Operating Environment: Hospital or other clinical setting. Possible operation in the field.
Deoxygenation Chamber
Material Specifications:
Physical:
Polycarbonate (PCB)
Environmental:
Storage Temperature: Maximum temperature: 93
℃
Operating Environment: Laboratory.
12.2 Ethics
Biomedical Engineering, as a discipline and profession, combines engineering techniques
with biological sciences, medicine, and technology, all in an effort to enhance the quality of
human life. Because the applications of Biomedical Engineering are designed to directly affect
the general public, it is necessary to consider public health and wellbeing at all times.
Biomedical Engineers must demonstrate ethical conduct in professional practice, research,
patient care and training. According to the Biomedical Engineering Society Code of Ethics, to
fulfill their professional engineering duties, Biomedical Engineers shall “use their knowledge,
skills, and abilities to enhance the safety, health, and welfare of the public” as well as “consider
the larger consequences of their work in regard to cost, availability, and delivery of health care.”
[22] When proposing a design for the microfluidic device, barriers to public health and safety
such as limited access to healthcare facilities were taken into consideration. The device was,
therefore, designed to be easily portable and simple to operate. Furthermore, the cost of the
device was kept reasonably low at approximately $1.40 per device. To provide maximum
comfort to the patient and reduce the possibility of biological exposure to the clinician operating
the device, the size of the blood sample required for accurate test results has been minimized.
Additionally, to keep record of material cost, an accurate budget was kept throughout the design
40

process. The BMES Code of Ethics also states that all Biomedical Engineers involved in
research shall “comply fully with legal, ethical, institutional, governmental, and other applicable
research guidelines, respecting the rights of and exercising the responsibilities to colleagues,
human and animal subjects, and the scientific and general public” as well as “publish and/or
present properly credited results of research accurately and clearly.” [22] Throughout the course
of this design project, all applicable research guidelines were abided by and the rights of others
were respected. All external sources of funding, technical assistance and scientific information
used in the completion of this project have been properly acknowledged and/or cited in this
report and in all associated project presentations. Furthermore, the results and conclusions
presented have not been altered or skewed in any way and represent our findings clearly and
truthfully.
12.3 Additional Information
See attached documents.
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